Federal Funding Opportunities March 27th-31st, 2023

NIH:

NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional)
(PA-23-134)
National Institutes of Health
Application Receipt Date(s): September 28, 2023
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
(PAR-23-122)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Human Genome Research Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of the Director, NIH
Office of Research on Women’s Health
Application Receipt Date(s): May 07, 2026
Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
(PAR-23-123)
National Human Genome Research Institute
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): June 01, 2023
Biological Testing Facility (X01 Clinical Trial Not Allowed)
(PAR-23-128)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 – Clinical Trial Not Allowed)
(PAR-23-140)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): June 02, 2023
Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
(RFA-AG-24-004)
National Institute on Aging
Application Receipt Date(s): July 03, 2023
Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
(RFA-AG-24-009)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 31, 2023
Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)
(RFA-AG-24-010)
National Institute on Aging
Application Receipt Date(s): July 02, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
(RFA-AI-23-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)
(RFA-AI-23-020)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
(RFA-AI-23-021)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 08, 2023
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
(RFA-CA-23-031)
National Cancer Institute
Application Receipt Date(s): May 05, 2023
NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-EB-23-002)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): May 31, 2023
Systematic Review of Clinical Outcome Assessments (COAs) for Communication Brain-Computer Interface Devices (cBCIs) in Amyotrophic Lateral Sclerosis (ALS) (UH2/UH3) Clinical Trials Not Allowed
(RFA-FD-23-030)
Food and Drug Administration
Application Receipt Date(s): May 24, 2023
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
(RFA-NS-24-004)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
(RFA-NS-24-005)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): January 20, 2026
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-23-004)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 08, 2023

NIA: